Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Author Correction: cBAF complex components and MYC cooperate early in CD8<sup>+</sup> T cell fate.

Nature·2026

Same author

Maternal trans-vaccenic acid shapes neonatal T cell development and early-life immune imprinting.

Science (New York, N.Y.)·2026

Same author

Large-scale, spatially resolved panoramic CRISPR screening in native tissue environments using Perturb-DBiT.

Nature biotechnology·2026

Same author

T cell Engineer: An interactive website to track CAR T cell negative regulators.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Same author

Regulatory heme: a mitochondria-to-nucleus messenger of CD8<sup>+</sup> T-cell exhaustion.

Cellular & molecular immunology·2026

Same author

Mitochondrial metabolism and signaling direct dendritic cell function in antitumor immunity.

Science (New York, N.Y.)·2026

Search research articles

Related Experiment Video

Updated: Jul 14, 2026

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

Published on: October 19, 2021

Tuning mTOR activity for immune balance.

Kai Yang, Hongbo Chi

The Journal of Clinical Investigation

|November 26, 2013

Summary

Loss of TSC1 in T cells boosts mTOR activity, promoting inflammatory Th1/Th17 responses and impairing regulatory T cells (Tregs). This disrupts the immune balance, worsening colitis in mice.

Area of Science:

Immunology
Cell Biology
Molecular Biology

Background:

The mechanistic target of rapamycin (mTOR) pathway is crucial for T cell functions and fate.
Regulation of mTOR signaling in T cell differentiation is not fully understood.
T cell-mediated immunity and tolerance involve a delicate balance.

Purpose of the Study:

To investigate the role of TSC1, an mTOR signaling regulator, in T cell differentiation.
To understand how TSC1 impacts the balance between T cell immunity and tolerance.
To elucidate the mechanisms underlying T cell dysfunction in the absence of TSC1.

Main Methods:

Utilized Tsc1-deficient mouse models.
Analyzed T cell differentiation, specifically Th1 and Th17 subsets.

More Related Videos

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry

Published on: May 24, 2024

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

Related Experiment Videos

Last Updated: Jul 14, 2026

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

Real-time Monitoring of Mitochondrial Respiration in Cytokine-differentiated Human Primary T Cells

Published on: October 19, 2021

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry

Author Spotlight: New Insights into PBMC Mitochondrial Responses Using Fluorespirometry

Published on: May 24, 2024

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays

Published on: April 18, 2025

Assessed regulatory T cell (Treg) suppressive activity.

Investigated the role of transcription factor Foxo3.

Main Results:

Enhanced mTOR activity in Tsc1-deficient T cells promoted Th1 and Th17 differentiation.
Tsc1-deficient T cells led to increased intestinal inflammation in murine colitis models.
Tsc1-deficient Tregs exhibited impaired suppressive activity under inflammatory conditions.
Defects in Tsc1-deficient Tregs were linked to effector-like phenotypes and exacerbated by Foxo3 loss.

Conclusions:

TSC1-mediated control of mTOR activity is critical for maintaining the balance between immunity and tolerance.
Dysregulation of mTOR signaling by TSC1 deficiency skews T cell responses towards inflammation.
Impaired Treg function in Tsc1-deficient cells contributes to inflammatory conditions.